<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03880604</url>
  </required_header>
  <id_info>
    <org_study_id>aswu/207/19</org_study_id>
    <nct_id>NCT03880604</nct_id>
  </id_info>
  <brief_title>Triple Tourniquets With or Without Tranexamic Acid for Reducing Blood Loss at Open Myomectomy</brief_title>
  <acronym>TTT</acronym>
  <official_title>Triple Tourniquets With or Without IV Tranexamic Acid for Reducing Blood Loss at Open Myomectomy: A Double-blinded Randomized Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aswan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aswan University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators will investigate the effectiveness of an intravenous
      tranexamic acid plus triple tourniquets compared with triple tourniquets alone for the
      reduction of blood loss at the time of myomectomy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An RCT investigated the efficacy of intravenous tranexamic acid (TA) during abdominal
      myomectomy. The study was unable to demonstrate any significant impact on blood loss,
      duration of surgery or need for blood transfusionHemostatic tourniquets to reduce
      intra‐operative bleeding have long been available, but data on their efficacy from controlled
      trials are lacking. The investigators set out to evaluate the use of triple tourniquets plus
      tranexamic acid in controlled conditions and for the first time to investigate the hypothesis
      that adding tranexamic acid to tourniquet around the uterine artery reduces postoperative
      bleeding from the uterine incisions, a well-recognized sequel to surgery
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A double-blinded randomized placebo-controlled trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>A double-blinded randomized placebo-controlled trial</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Mean amount of intraoperative blood loss</measure>
    <time_frame>intraoperative</time_frame>
    <description>measure the mean amount of intraoperative blood loss by gravimetric methods</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The number of patients needs for blood transfusion</measure>
    <time_frame>24 hours post delivery</time_frame>
    <description>Calculation the number of patients needs for blood transfusion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Myoma</condition>
  <arm_group>
    <arm_group_label>Triple tourniquets plus TA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A number 1 polyglactin suture was tied around the cervix to occlude the uterine arteries, and polythene tourniquets were tied around the infundibulopelvic ligament to obstruct the ovarian vessels.plus1-gram tranexamic acid (10 ml) in 100 ml saline infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Triple tourniquets plus placebo to TA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A number 1 polyglactin suture was tied around the cervix to occlude the uterine arteries, and polythene tourniquets were tied around the infundibulopelvic ligament to obstruct the ovarian vessels.plus placebo to 1-gram tranexamic acid (10 ml) in 100 ml saline infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Triple tourniquets</intervention_name>
    <description>A number 1 polyglactin suture was tied around the cervix to occlude the uterine arteries, and polythene tourniquets were tied around the infundibulopelvic ligament to obstruct the ovarian vessels</description>
    <arm_group_label>Triple tourniquets plus TA</arm_group_label>
    <arm_group_label>Triple tourniquets plus placebo to TA</arm_group_label>
    <other_name>Active comparator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TA</intervention_name>
    <description>1-gram tranexamic acid (10 ml) in 100 ml saline infusion</description>
    <arm_group_label>Triple tourniquets plus TA</arm_group_label>
    <other_name>Active Comparator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo to TA</intervention_name>
    <description>placebo to 1-gram tranexamic acid (10 ml) in 100 ml saline infusion</description>
    <arm_group_label>Triple tourniquets plus placebo to TA</arm_group_label>
    <other_name>placebo comparator</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting for abdominal myomectomy with documented uterine fibroids on
             ----pelvic imaging

          -  Age ≥ 18 years and ≤ 50 years

          -  Pre-operative hemoglobin &gt;8 g/dl

          -  Ability to understand and the willingness to sign a written informed consent.

          -  Admissible medical/surgical history

          -  Five or less symptomatic uterine myomas

          -  All myomas are subserous or intramural.

          -  Uterine size less than 24 weeks of pregnancy

        Exclusion Criteria:

          -  Patients who have had a prior abdominal myomectomy

          -  Post-menopausal women

          -  Patients with known bleeding/clotting disorders

          -  Patients with a history of gynecologic malignancy

          -  Hypertension.

          -  Cardiac and Pulmonary Diseases.

          -  Obesity (body mass index &gt; 30 kg/m2).

          -  History of allergic reactions attributed to misoprostol

          -  Cases that will require intraoperative conversion of myomectomy to hysterectomy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>All women who prepared for abdominal myomectomies will be invited to participate in the study</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>hany f sallam, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aswan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>hany f sallam, md</last_name>
    <phone>0102236052</phone>
    <phone_ext>002</phone_ext>
    <email>hany.farouk@aswu.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>nahla w shady, md</last_name>
    <phone>01092440504</phone>
    <phone_ext>002</phone_ext>
    <email>nahla.elsayed@aswu.edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aswan University Hospital</name>
      <address>
        <city>Aswan</city>
        <zip>81528</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hany f Sallam, MD</last_name>
      <phone>0122336052</phone>
      <phone_ext>002</phone_ext>
      <email>hany.farouk@aswu.edu.eg</email>
    </contact>
    <contact_backup>
      <last_name>Nahla W Shady, MD</last_name>
      <phone>01092440504</phone>
      <phone_ext>002</phone_ext>
      <email>nahla.elsayed@aswu.edu.eg</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>March 15, 2019</study_first_submitted>
  <study_first_submitted_qc>March 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2019</study_first_posted>
  <last_update_submitted>May 10, 2019</last_update_submitted>
  <last_update_submitted_qc>May 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aswan University Hospital</investigator_affiliation>
    <investigator_full_name>hany farouk</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Haemostatic tourniquets</keyword>
  <keyword>tranexamic acid</keyword>
  <keyword>myomectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

